Legal & General Group
ALPN

Legal & General Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Legal & General Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,901
Closed -$1.22M – 3562
2024
Q1 		$1.22M Buy
30,901
+4,638
+18% +$137K ﹤0.01% 2128
2023
Q4 		$501K Buy
26,263
+3,548
+16% +$49.3K ﹤0.01% 2447
2023
Q3 		$260K Buy
22,715
+19,223
+550% +$237K ﹤0.01% 2656
2023
Q2 		$35.9K Buy
3,492
+1,019
+41% +$9.19K ﹤0.01% 2918
2023
Q1 		$19.1K Hold
2,473
– – ﹤0.01% 3078
2022
Q4 		$18.2K Buy
2,473
+1,031
+71% +$6.59K ﹤0.01% 3177
2022
Q3 		$10K Hold
1,442
– – ﹤0.01% 3344
2022
Q2 		$12K Buy
1,442
+215
+18% +$1.85K ﹤0.01% 3356
2022
Q1 		$11K Hold
1,227
– – ﹤0.01% 3389
2021
Q4 		$17K Hold
1,227
– – ﹤0.01% 3337
2021
Q3 		$13K Hold
1,227
– – ﹤0.01% 3405
2021
Q2 		$11K Buy
+1,227
New +$13.3K ﹤0.01% 3414

Legal & General Group's ALPN Position: Q2 2024 in Review

Legal & General Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 30,901 shares — an estimated $1.22M sold.

Legal & General Group first reported a position in ALPN in Q2 2021 and held it in 12 quarters. The position peaked at $1.22M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Legal & General Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 30,901 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.22M.
  • Legal & General Group first reported a position in Alpine Immune Sciences Inc in Q2 2021 and held it in 12 quarters.
  • Legal & General Group's Alpine Immune Sciences Inc position peaked at $1.22M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.